Neurology News and Articles

Ascorbic acid in Charcot—Marie—Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial The Lancet Neurology, 04/05/2011

Pareyson D et al. – Ascorbic acid supplementation had no significant effect on neuropathy compared with placebo after 2 years, suggesting that no evidence is available to support treatment with ascorbic acid in adults with Charcot—Marie—Tooth disease type 1AV

Read this article on The Lancet Neurology



Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Connect with us, stay current.

Receive the latest mecial news
updates for free via email

Sign up!

Subscribe to our free RSS feeds:

Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Close